Long-Term Effects of Secondary Prevention on Cognitive Function in Stroke Patients

被引:93
作者
Douiri, Abdel [1 ]
McKevitt, Christopher
Emmett, Eva S.
Rudd, Anthony G.
Wolfe, Charles D. A.
机构
[1] Kings Coll London, Div Hlth & Social Care Res, London SE1 3QD, England
关键词
drug therapy; mild cognitive impairment; prevention & control; stroke; vascular dementia; HEALTH-CARE PROFESSIONALS; TRANSIENT ISCHEMIC ATTACK; MINI-MENTAL-STATE; GUIDELINES; IMPAIRMENT; DEMENTIA; MANAGEMENT;
D O I
10.1161/CIRCULATIONAHA.113.002236
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background Limited long-term follow-up data exist on the impact of appropriate secondary prevention therapies on cognitive function in patients after first-ever stroke. The aim of this study is to determine the effect of secondary prevention of vascular events on cognitive function after stroke. Methods and Results Data were collected between 1995 and 2011 (n=4413) from the community-based South London Stroke Register covering an inner-city multiethnic source population of 271 817 inhabitants. Modified Poisson regression models were constructed to adjust for cognitive function status at 3 months, demographic and socioeconomic characteristics, case mix, stroke subtype, vascular risk factors, disability, and stroke recurrence. In patients with ischemic strokes without a history of atrial fibrillation (AF), there was a reduced risk of cognitive impairment associated with the use of different prevention treatments: (1) antihypertensives (relative risk, 0.7 [95% confidence interval, 0.57-0.82] for diuretics; relative risk, 0.8 [95% confidence interval, 0.64-0.98] for angiotensin-converting enzyme inhibitors; and relative risk, 0.7 [95% confidence interval, 0.55-0.81] for their combination), (2) a combination of aspirin and dipyridamole (relative risk, 0.8 [95% confidence interval, 0.68-1.01]), and (3) statin (relative risk, 0.9 [95% confidence interval, 0.76-1.06]) when clinically indicated. Protective effects against cognitive impairment were also observed in patients on the combination of antihypertensives, antithrombotic agents, and lipid-lowering drugs (relative risk, 0.55 [95% confidence interval, 0.40-0.77]). No significant associations were noted between poststroke cognitive impairment and antihypertensives among hemorrhagic stroke patients. Conclusions Appropriate vascular risk management was associated with a long-term reduced risk of cognitive impairment. Focus on optimal preventive drug therapy of vascular risk factors and management should be supported.
引用
收藏
页码:1341 / 1348
页数:8
相关论文
共 32 条
[1]
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack [J].
Adams, Robert J. ;
Albers, Greg ;
Alberts, Mark J. ;
Benavente, Oscar ;
Furie, Karen ;
Goldstein, Larry B. ;
Gorelick, Philip ;
Halperin, Jonathan ;
Harbaugh, Robert ;
Johnston, S. Claiborne ;
Katzan, Irene ;
Kelly-Hayes, Margaret ;
Kenton, Edgar J. ;
Marks, Michael ;
Sacco, Ralph L. ;
Schwamm, Lee H. .
STROKE, 2008, 39 (05) :1647-1652
[2]
Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors [J].
Allan, Louise M. ;
Rowan, Elise N. ;
Firbank, Michael J. ;
Thomas, Alan J. ;
Parry, Stephen W. ;
Polvikoski, Tuomo M. ;
O'Brien, John T. ;
Kalaria, Raj N. .
BRAIN, 2011, 134 :3713-3724
[3]
Clinical trials for preventing post stroke cognitive impairment [J].
Ankolekar, Sandeep ;
Geeganage, Chamila ;
Anderton, Peter ;
Hogg, Cheryl ;
Bath, Philip M. W. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 299 (1-2) :168-174
[4]
CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION [J].
BAMFORD, J ;
SANDERCOCK, P ;
DENNIS, M ;
BURN, J ;
WARLOW, C .
LANCET, 1991, 337 (8756) :1521-1526
[5]
How predictive is the MMSE for cognitive performance after stroke? [J].
Bour, Ariane ;
Rasquin, Sascha ;
Boreas, Anita ;
Limburg, Martien ;
Verhey, Frans .
JOURNAL OF NEUROLOGY, 2010, 257 (04) :630-637
[6]
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial:: a double-blind, active and placebo-controlled study [J].
Dienert, Hans-Christoph ;
Saccot, Ralph L. ;
Yusuft, Salim ;
Cotton, Daniel ;
Ounpuu, Stephanie ;
Lawton, William A. ;
Palesch, Yuko ;
Martin, Renee H. ;
Albers, Gregory W. ;
Bath, Philip ;
Bornstein, Natan ;
Chan, Bernard P. L. ;
Chen, Sien-Tsong ;
Cunha, Luis ;
Dahlof, Bjorn ;
De Keyser, Jacques ;
Donnan, Geoffrey A. ;
Estol, Conrado ;
Gorelick, Philip ;
Gu, Vivian ;
Hermansson, Karin ;
Hilbrich, Lutz ;
Kaste, Markku ;
Lu, Chuanzhen ;
Machnig, Thomas ;
Pais, Prem ;
Roberts, Robin ;
Skvortsova, Veronika ;
Teal, Philip ;
Toni, Danilo ;
VanderMaelen, Cam ;
Voigt, Thor ;
Weber, Michael ;
Yoon, Byung-Woo .
LANCET NEUROLOGY, 2008, 7 (10) :875-884
[7]
Prevalence of Poststroke Cognitive Impairment South London Stroke Register 1995-2010 [J].
Douiri, Abdel ;
Rudd, Anthony G. ;
Wolfe, Charles D. A. .
STROKE, 2013, 44 (01) :138-145
[8]
Framingham stroke risk profile and lowered cognitive performance [J].
Elias, MF ;
Sullivan, LM ;
D'Agostino, RB ;
Elias, PK ;
Beiser, A ;
Au, R ;
Seshadri, S ;
DeCarli, C ;
Wolf, PA .
STROKE, 2004, 35 (02) :404-409
[9]
MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[10]
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [J].
Furie, Karen L. ;
Kasner, Scott E. ;
Adams, Robert J. ;
Albers, Gregory W. ;
Bush, Ruth L. ;
Fagan, Susan C. ;
Halperin, Jonathan L. ;
Johnston, S. Claiborne ;
Katzan, Irene ;
Kernan, Walter N. ;
Mitchell, Pamela H. ;
Ovbiagele, Bruce ;
Palesch, Yuko Y. ;
Sacco, Ralph L. ;
Schwamm, Lee H. ;
Wassertheil-Smoller, Sylvia ;
Turan, Tanya N. ;
Wentworth, Deidre .
STROKE, 2011, 42 (01) :227-276